Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18f]fluoro-2-deoxy-d-glucose

This publication has 16 references indexed in Scilit:

• Diagnostic and Prognostic Value of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma
  Journal of Clinical Oncology, 2002
• Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
  The Lancet, 2002
• Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy
  Journal of Clinical Oncology, 2002
• FDG–PET. A possible prognostic factor in head and neck cancer
  British Journal of Cancer, 2002
• Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Impact of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography on Patient Management: First Year’s Experience in a Clinical Center
  Journal of Clinical Oncology, 2001
• Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Surfing prognostic factors in head and neck cancer at the Millennium
  Oral Oncology, 1999
• Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-¹⁸FDG PET
  Acta Oncologica, 1997